Finland· FI-REL-REL59466

DUOMYXIN

A antibioottien yhdistelmävalmisteet product containing neomycin sulfate + polymyxin b sulfate, registered in Finland by Domes Pharma. The same ATC class is registered in 2 of our 19 countries.

ATC QS01AA30

Checked against Fimea (Finland) on

Informational only — not a medical device.

SOURCE REGISTER · FIFimea (Finland)normalisedDUOMYXINATCQS01AA30REGISTER NO.FI-REL-REL59466PACKS LISTED0CHECKEDSeptember 27, 2026

Where it is registered

Neomycin sulfate + polymyxin b sulfate is registered in 2 of 19 countries.

Countries holding a registration under ATC QS01AA30 (antibioottien yhdistelmävalmisteet), each read from that country’s own register.

  • This record: Finland, from Fimea (Finland)
  • 1 of them publish a price we can compare per daily dose

Neomycin sulfate + polymyxin b sulfate · ATC QS01AA30

2 / 19 countries

  • Denmark
  • Finlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Fimea (Finland)
Active substance
Neomycin sulfate + Polymyxin b sulfate
Manufacturer
Domes Pharma
Country
Finland (FI)
ATC code
QS01AA30
ATC class
Antibioottien yhdistelmävalmisteet
Reimbursed
Not published by this register
Source register
Fimea (Finland)
Last checked
September 27, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Neomycin sulfate + polymyxin b sulfate in 1 other country

What each register calls a product with the same active substance — salts and hydrates count as the same.

All neomycin sulfate + polymyxin b sulfate products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b15d30e8-c65b-4905-9213-7cc2160d1a07
GET /v1/drugs/b15d30e8-c65b-4905-9213-7cc2160d1a07?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "ddd": null,
  "form": "silmätipat, jauhe ja liuotin liuosta varten",
  "route": "Silmän pinnalle",
  "ddd_unit": null,
  "strength": "3400 IU/ml / 10000 IU/ml",
  "atc_label": "Antibioottien yhdistelmävalmisteet",
  "ma_number": "40405",
  "auth_status": "Myyntilupa myönnetty",
  "eu_ma_number": null,
  "fimea_rel_id": "REL59466",
  "authorised_at": "2022-12-16"
}

See everything about neomycin sulfate + polymyxin b sulfate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.